Quality, Purity, and Testing Standards In the gray-market chemical landscape, transparency is everything
THE GH, IGF-1, AND INSULIN INTERPLAY IN TYPE 1 DIABETES MELLITUS THE GH, IGF-1, AND INSULIN INTERPLAY IN TYPE 2 DIABETES MELLITUS AND OBESITY THE GH, IGF-1, AND INSULIN INTERPLAY IN LIVER FAILURE THE GH, IGF-1, AND INSULIN INTERPLAY IN ACROMEGALY CONCLUSIONS Article information References ABSTRACT This review intends to provide the reader with a practical overview of several (patho)physiological conditions in which knowledge of the interplay between growth hormone (GH), insulin-like growth factor-1 (IGF-1), and insulin is important
Tesamorelin is a GHRH analog, the only peptide in its class with FDA approval (for HIV-associated lipodystrophy), and it drives fat breakdown specifically in visceral adipose tissue
The no-DAC form is the one most peptide clinics use, and it is almost always paired with Ipamorelin
Gonadotropins Increased GH and IGF1 levels can influence gonadotropin secretion